NAFLD

This study tested whether a natural plant compound called phytosterol can help people with non-alcoholic fatty liver disease (NAFLD). Twenty-seven adults took the supplement for three months to see if it improved liver enzymes, cholesterol, insulin levels, and inflammation. The g…

This study tested an experimental drug called elobixibat in 47 adults with nonalcoholic fatty liver disease (NAFLD) or its more serious form, NASH. Participants received either the drug or a placebo for 16 weeks. The main goal was to see if elobixibat could lower LDL (bad) choles…

This study tested two versions of a low-calorie Mediterranean diet, each with different carb and fat levels, combined with moderate aerobic exercise in 36 adults with obesity and fatty liver disease (NAFLD). The goal was to see if one diet plan worked better than the other at red…

This study looked at 60 teenage girls with PCOS, obesity, and fatty liver disease. Half received the drug semaglutide, and the other half followed a special diet for 12 weeks. The goal was to see which approach better reduced liver fat and improved how the body uses insulin.

This study looked at whether adding tomatoes to the diet can improve liver health, gut function, and blood sugar in people with non-alcoholic fatty liver disease (NAFLD). 80 adults with NAFLD and a BMI of 30 or less followed a tomato-enriched diet for 6 weeks. Researchers measure…

This study tested a new medicine called efinopegdutide in 381 adults with non-alcoholic steatohepatitis (NASH), a serious fatty liver disease. The main goal was to see if the drug could reverse liver inflammation without making scarring worse, compared to a placebo. Researchers a…

This pilot study tested a drug called ibutamoren in 12 adults with nonalcoholic fatty liver disease (NAFLD). The goal was to see if it could reduce fat buildup in the liver. Participants took the medication for 6 months, and researchers measured liver fat using a special MRI scan…

This study tested whether a combination of two drugs, dasatinib and quercetin, can reduce liver scarring in people with non-alcoholic fatty liver disease (NAFLD) and fibrosis. Thirty adults with biopsy-confirmed liver scarring took part in a 21-week randomized, double-blind trial…

This study tested a new drug called DD01 in 67 overweight or obese adults with a type of fatty liver disease (MASLD or MASH). The goal was to see if DD01 could safely reduce liver fat over 48 weeks. Participants were randomly assigned to receive DD01 or a placebo, and researchers…

This study looked at how common and severe fatty liver disease is in people with type 2 diabetes. Researchers used advanced MRI scans to measure liver fat, inflammation, and scarring. 317 patients were checked twice, three years apart, to see how the disease changes over time. Th…

This study looked at how the hormone glucagon affects the liver's ability to break down amino acids and produce sugar. Researchers compared lean and obese people, some with type 2 diabetes and fatty liver, to see if the liver becomes resistant to glucagon. The goal was to better …

This study looked at whether two blood tests, eLIFT and FibroMeter, can accurately detect liver fibrosis (scarring) in people with type 2 diabetes. Liver fibrosis is common in diabetes and can lead to serious liver problems, but the best way to check for it is a liver biopsy, whi…

This study looked at 1005 people with non-alcoholic fatty liver disease (NAFLD) to find better ways to check liver damage without using a needle biopsy. Researchers tested blood tests and special ultrasound devices to see how well they can spot serious liver scarring. The goal is…

This study looked at how people with chronic liver disease (like hepatitis B, C, or fatty liver) respond to COVID-19 vaccines. About 233 adults had blood tests and answered questions over three visits, each six months apart. The goal was to see if liver disease severity affects v…

This study looked at the financial impact of non-alcoholic fatty liver disease (NAFLD) on patients and the healthcare system in Flanders, Belgium. Researchers surveyed 73 adults with NAFLD to measure their medical costs and quality of life. The goal was to understand how much thi…

This study tested a new type of MRI that lets children breathe normally during the scan, instead of holding their breath. The goal was to see if it can accurately measure liver fat and stiffness, which helps diagnose fatty liver disease and liver scarring. 135 children aged 6-17 …